GOLGA6A activators constitute a specialized category of chemical agents that influence the biological pathway involving the Golgin A6 family member A protein, encoded by the GOLGA6A gene. The protein is part of the golgin subfamily of the coiled-coil type of proteins, which are localized predominantly in the Golgi apparatus of cells. This complex network of proteins plays a crucial role in the structure and function of the Golgi apparatus, which is pivotal for the sorting and modification of proteins and lipids in the cell. GOLGA6A activators interact at the molecular level with the GOLGA6A protein, modulating its function. The precise mechanism by which these activators exert their influence can vary, but it generally involves promoting or enhancing the activity of the GOLGA6A protein, thus affecting the dynamics of Golgi apparatus assembly and maintenance, as well as influencing vesicular trafficking processes that are essential for cellular homeostasis and function.
Understanding the biochemical mechanisms that underpin the function of GOLGA6A activators requires a deep dive into the molecular interactions that govern protein activity within the cellular environment. These activators may act by binding directly to the GOLGA6A protein, altering its conformation in a way that augments its natural activity or stability within the cell. Alternatively, they might interact with regulatory elements or partner proteins that modulate the function of the GOLGA6A protein, thereby indirectly impacting its activity. The modulation of GOLGA6A can have significant downstream effects, given the protein's involvement in critical cellular processes. As such, the study of GOLGA6A activators encompasses a detailed exploration of protein chemistry and cell biology, focusing on the intricate dance of molecular interactions that sustain cellular organization and logistics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
A fungal metabolite that disrupts Golgi structure by inhibiting ARF1, subsequently causing a compensatory response that can enhance the activity of GOLGA6A for maintaining Golgi integrity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule-disrupting agent that activates cellular stress response pathways, leading to enhanced activity of GOLGA6A as the cell attempts to maintain Golgi apparatus structure during stress. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases cAMP levels, which may indirectly enhance the activity of GOLGA6A via PKA signaling pathways involved in membrane trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that alters Golgi apparatus ion homeostasis, potentially enhancing GOLGA6A activity through the modulation of Golgi pH and trafficking functions. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Protein phosphatase inhibitor that can enhance phosphorylation states of proteins involved in vesicle trafficking, indirectly enhancing GOLGA6A activity in Golgi apparatus maintenance. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
A specific inhibitor of the Golgi BFA resistance factor 1 (GBF1), leading to Golgi stress that could indirectly enhance GOLGA6A activity as part of the cellular compensatory mechanisms. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibitor of GSK-3, which may lead to enhanced activity of GOLGA6A through Wnt signaling pathways, indirectly affecting Golgi apparatus function and maintenance. | ||||||